Psoriasis Clinical Trial

Clinical Trial Finder Psoriasis Trials

Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

See Locations Near You

Summary

Compare the efficacy of ABT-874 versus etanercept in subjects with moderate to severe plaque psoriasis

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosis of Psoriasis for 6 MO
BSA 10%
PASI 12 or above
PGA 3 or above

Exclusion Criteria:

Previous exposure to either etanercept or ABT-874

Study is for people with:

Psoriasis

Phase:

Phase 3

Estimated Enrollment:

350

Study ID:

NCT00710580

Recruitment Status:

Completed

Sponsor:

AbbVie (prior sponsor, Abbott)

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 41 Locations for this study

See Locations Near You

Site Reference ID/Investigator# 9984
Birmingham Alabama, 35205, United States
Site Reference ID/Investigator# 10605
Birmingham Alabama, 35233, United States
Site Reference ID/Investigator# 10001
Scottsdale Arizona, 85251, United States
Site Reference ID/Investigator# 10502
Little Rock Arkansas, 72205, United States
Site Reference ID/Investigator# 9985
Bakersfield California, 93309, United States
Site Reference ID/Investigator# 10661
Irvine California, 92697, United States
Site Reference ID/Investigator# 14701
Los Angeles California, 90045, United States
Site Reference ID/Investigator# 9785
San Diego California, 92123, United States
Site Reference ID/Investigator# 10662
Santa Monica California, 90404, United States
Site Reference ID/Investigator# 10642
Vallejo California, 94589, United States
Site Reference ID/Investigator# 10263
New Haven Connecticut, 06511, United States
Site Reference ID/Investigator# 10503
Jacksonville Florida, 32204, United States
Site Reference ID/Investigator# 10266
Miami Florida, 33144, United States
Site Reference ID/Investigator# 9901
Miami Florida, 33173, United States
Site Reference ID/Investigator# 10501
West Palm Beach Florida, 33407, United States
Site Reference ID/Investigator# 15201
Alpharetta Georgia, 30022, United States
Site Reference ID/Investigator# 10762
Atlanta Georgia, 30327, United States
Site Reference ID/Investigator# 10262
Newnan Georgia, 30263, United States
Site Reference ID/Investigator# 9789
Snellville Georgia, 30078, United States
Site Reference ID/Investigator# 10666
Maywood Illinois, 60153, United States
Site Reference ID/Investigator# 15142
Plainfield Indiana, 46168, United States
Site Reference ID/Investigator# 10265
Louisville Kentucky, 40202, United States
Site Reference ID/Investigator# 15750
Owensboro Kentucky, 42303, United States
Site Reference ID/Investigator# 9790
Owensboro Kentucky, 42303, United States
Site Reference ID/Investigator# 9788
Fort Gratiot Michigan, 48059, United States
Site Reference ID/Investigator# 10604
Grand Blanc Michigan, 48439, United States
Site Reference ID/Investigator# 10541
Fridley Minnesota, 55432, United States
Site Reference ID/Investigator# 10641
St. Louis Missouri, 63110, United States
Site Reference ID/Investigator# 10606
Omaha Nebraska, 68131, United States
Site Reference ID/Investigator# 10644
Omaha Nebraska, 68144, United States
Site Reference ID/Investigator# 9786
Berlin New Jersey, 08009, United States
Site Reference ID/Investigator# 10241
New York New York, 10016, United States
Site Reference ID/Investigator# 9787
Rochester New York, 14623, United States
Site Reference ID/Investigator# 9902
Hickory North Carolina, 28601, United States
Site Reference ID/Investigator# 10581
Wilmington North Carolina, 28401, United States
Site Reference ID/Investigator# 10504
Dayton Ohio, 45408, United States
Site Reference ID/Investigator# 10643
Knoxville Tennessee, 37934, United States
Site Reference ID/Investigator# 9981
Dallas Texas, 75230, United States
Site Reference ID/Investigator# 10264
San Antonio Texas, 78229, United States
Site Reference ID/Investigator# 9982
Webster Texas, 77598, United States
Site Reference ID/Investigator# 10182
Seattle Washington, 98101, United States
Site Reference ID/Investigator# 10321
Milwaukee Wisconsin, 53209, United States
Load More

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Phase:

Phase 3

Estimated Enrollment:

350

Study ID:

NCT00710580

Recruitment Status:

Completed

Sponsor:


AbbVie (prior sponsor, Abbott)

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider